Europe Losing Pharma Innovation Race to US, China

Europe's share of new drug substances is declining relative to the US and China, which are ahead in novel drug development. Asia's advantage is growing due to lower R&D costs. Europe retains potential but must accelerate to regain competitiveness.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works